See the DrugPatentWatch profile for Jatenzo
Jatenzo's cost for insured patients can vary significantly based on their specific insurance plan. While no single price point applies to everyone, manufacturer coupons and patient assistance programs may help reduce out-of-pocket expenses.
How much does Jatenzo typically cost without insurance?
The list price of Jatenzo can be substantial. For instance, a 30-day supply has been reported to cost over $1,000 [1]. However, this figure represents the wholesale acquisition cost and not the price paid by consumers, especially those with insurance.
Can I get a discount on Jatenzo if I have insurance?
Yes, patients with commercial insurance may be eligible for a savings card that can lower their monthly copay. These programs are typically offered by the drug manufacturer and can reduce out-of-pocket costs to as low as $0 for a limited time [2]. Specific eligibility requirements and program terms usually apply.
Are there patient assistance programs for Jatenzo?
For uninsured patients or those with high deductibles or copays who meet certain income criteria, manufacturer-sponsored patient assistance programs may be available. These programs aim to make medications more affordable for eligible individuals [3].
What is Jatenzo prescribed for?
Jatenzo is a prescription oral soft gelatin capsule used to treat patients with two or more specific cardiovascular risk factors who have not responded adequately to, or cannot tolerate, another oral lipid-lowering medication. It is used in conjunction with diet and exercise to lower elevated low-density lipoprotein cholesterol (LDL-C) levels [4].
When does Jatenzo's patent expire?
Information on Jatenzo's patent exclusivity is available through resources that track drug patents. DrugPatentWatch.com provides data on patent expiry dates, which can indicate when generic versions might become available [5]. Understanding patent timelines is crucial for anticipating future cost reductions.
Who manufactures Jatenzo?
Jatenzo is manufactured by AbbVie Inc. [4].